Murase Yoshiki, Ban Daisuke, Maekawa Aya, Watanabe Shuichi, Ishikawa Yoshiya, Akahoshi Keiichi, Ogawa Kosuke, Ono Hiroaki, Kudo Atsushi, Kudo Toshifumi, Tanaka Shinji, Tanabe Minoru
Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
Division of Vascular and Endovascular Surgery, Department of Surgery, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
Surg Case Rep. 2020 Dec 1;6(1):302. doi: 10.1186/s40792-020-01082-7.
Pancreatic cancer is a disease with a poor prognosis, requiring multidisciplinary treatment combining chemotherapy and surgery for effective management. Distal pancreatectomy with celiac axis resection (DP-CAR) is a surgical intervention performed for locally advanced pancreatic cancer, but the benefit of arterial reconstruction in DP-CAR is unclear.
A 49-year-old man with pancreatic cancer was referred to our hospital. Imaging revealed a 54-mm tumor mainly in the pancreatic body, but with arterial infiltration including into the celiac, common hepatic, left gastric, splenic and gastroduodenal arteries. Distant metastases were not detected. The patient was diagnosed with unresectable locally advanced pancreatic cancer and chemoradiotherapy was planned. Three cycles of gemcitabine (1000 mg/m) plus nab-paclitaxel (125 mg/m) every 4 weeks were followed by irradiation (2 Gy/day, total 50 Gy over 25 days) together with S-1 administration (80 mg/m/day). A partial response (PR) according to Response Evaluation Criteria in Solid Tumors (RECIST) was achieved, so surgical intervention was considered. Because the tumor had invaded the root of the gastroduodenal artery, we performed DP-CAR with resection of the gastroduodenal artery, followed by arterial reconstruction of the proper hepatic and left gastric arteries, anastomosed with the abdominal aorta using a great saphenous vein graft in the shape of a "Y". Histopathology showed that 60% of tumor cells were destroyed by the chemoradiotherapy, defined as grade IIb in the Evans classification. No malignancy was detected at the surgical margin, including the celiac artery, gastroduodenal artery or pancreatic stump; thus R0 surgery was successful. S-1 (80 mg/day) was administered as adjuvant chemotherapy for 6 months. The patient is now doing well without recurrence for > 2 years after the initial treatment (more than 16 months after surgery).
For locally advanced pancreatic cancer, multidisciplinary treatment combining gemcitabine/nab-paclitaxel-based chemoradiotherapy and then DP-CAR surgery with gastroduodenal artery resection and arterial reconstruction using saphenous vein grafting enabled R0 resection in this patient and led to a favorable long-term prognosis.
胰腺癌预后较差,需要化疗与手术相结合的多学科治疗才能有效控制。保留腹腔干的胰体尾切除术(DP-CAR)是针对局部进展期胰腺癌实施的一种手术干预,但DP-CAR中动脉重建的益处尚不清楚。
一名49岁的胰腺癌男性患者被转诊至我院。影像学检查发现一个54毫米的肿瘤,主要位于胰体,但已侵犯包括腹腔干、肝总动脉、胃左动脉、脾动脉和胃十二指肠动脉在内的多条动脉。未检测到远处转移。该患者被诊断为不可切除的局部进展期胰腺癌,并计划进行放化疗。每4周给予3个周期的吉西他滨(1000mg/m²)加白蛋白结合型紫杉醇(125mg/m²),随后进行放疗(2Gy/天,25天内共50Gy),同时给予S-1(80mg/m²/天)。根据实体瘤疗效评价标准(RECIST)达到了部分缓解(PR),因此考虑进行手术干预。由于肿瘤侵犯了胃十二指肠动脉根部,我们实施了保留腹腔干的胰体尾切除术并切除胃十二指肠动脉,随后用大隐静脉“Y”形移植对肝固有动脉和胃左动脉进行动脉重建,并与腹主动脉吻合。组织病理学显示,60%的肿瘤细胞被放化疗破坏,在埃文斯分类中定义为IIb级。在手术切缘,包括腹腔干、胃十二指肠动脉或胰腺残端均未检测到恶性肿瘤;因此R0手术成功。给予S-1(80mg/天)作为辅助化疗,持续6个月。该患者目前情况良好,初始治疗后(手术后超过16个月)已超过2年无复发。
对于局部进展期胰腺癌,基于吉西他滨/白蛋白结合型紫杉醇的放化疗联合保留腹腔干的胰体尾切除术及胃十二指肠动脉切除和大隐静脉移植动脉重建的多学科治疗,使该患者实现了R0切除,并带来了良好的长期预后。